• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

ev3 Inc.

Medtronic shareholder sues over company’s plan to cover nearly $58M in taxes | Medtech legal news for the week of October 13, 2014

October 13, 2014 By MassDevice Leave a Comment

Shareholder sues Medtronic over plan to cover execs' $58m tax tab

October 7, 2014 by Brad Perriello

Filed Under: Legal News, News Well Tagged With: Abbott, Advanced Medical Optics, Appriva Medical, becton dickinson, C.R. Bard, Covidien, ev3 Inc., Legal Roundup, Retractable Technologies Inc., Securities & Exchange Commission (SEC)

Covidien’s Ev3 logs a pair of legal wins over Appriva, whistleblower

October 8, 2014 By Brad Perriello Leave a Comment

Covidien's ev3 logs a pair of legal wins over Appriva, whistleblower

Filed Under: Legal News, News Well Tagged With: Appriva Medical, Covidien, ev3 Inc., Neurovascular repair

Medtech legal news for the week of Mar. 17, 2014

March 17, 2014 By MassDevice staff Leave a Comment

Appeals court applies Supreme Court ruling to Medtronic lawsuit against Boston Scientific

March 12, 2014 by Brad Perriello

Filed Under: Legal News, News Well Tagged With: Abbott, Appriva Medical, becton dickinson, Boston Scientific, Covidien, Equal Employment Opportunity Commission (EEOC), ev3 Inc., ISOL Technology, LBDS Holding Co., Legal Roundup, Nova BioMedical, PMT Medical, Therasense, U.S. Court of Appeals for the Federal Circuit, U.S. Supreme Court

Covidien’s ev3 seeks new trial in $175M loss to Appriva

March 13, 2014 By Brad Perriello Leave a Comment

Covidien's ev3 seeks new trial in $175M loss to Appriva

Covidien (NYSE:COV) subsidiary ev3 wants the Delaware Supreme Court to grant a new trial in a lawsuit over $175 million ev3 allegedly owes its own Appriva Medical acquisition.

Filed Under: Legal News, Mergers & Acquisitions, News Well Tagged With: Appriva Medical, Covidien, ev3 Inc.

Covidien’s got a ‘new approach’ to peripheral arterial disease

October 15, 2013 By Arezu Sarvestani Leave a Comment

Covidien's got a 'new approach' to peripheral arterial disease

Filed Under: News Well, Stents Tagged With: Clinical Trials, Covidien, ev3 Inc., Peripheral

Jury hands Covidien’s ev3 subsidiary a possible $275M loss

August 13, 2013 By Brad Perriello Leave a Comment

Jury hands Covidien's ev3 subsidiary a possible $265M loss

Covidien (NYSE:COV) is on the hook for a $175 million milestone owed by subsidiary ev3 Inc. to a company it acquired 11 years ago, plus another possible $100 million in interest, after a Delaware jury’s decision last May.

Filed Under: Cardiac Implants, Legal News, News Well Tagged With: Appriva Medical, Breach of Contract, Covidien, ev3 Inc.

Aneurysm: Covidien touts pivotal study on Pipeline embolization device

June 17, 2013 By Brian Johnson Leave a Comment

Aneurysm: Covidien touts pivotal study on Pipeline embolization device

Covidien (NYSE:COV) subsidiary ev3 Inc. is touting the results of a pivotal trial of its Pipeline aneurysm embolization device, showing that the technology "offers a reasonably safe and effective treatment of large or giant intracranial internal carotid artery aneurysms."

Filed Under: News Well Tagged With: Clinical Trials, Coil Embolization, Covidien, ev3 Inc., Radiological Society of North America

Mixed feelings for Covidien’s Pipeline embolization device following deaths

December 6, 2012 By MassDevice staff Leave a Comment

eV3's Pipeline embolization device

Researchers offered mixed messages on the safety and effectiveness of Covidien (NYSE:COV) subsidiary ev3 Inc.’s Pipeline embolization device, lauding the system as an option for patients with aneurysms that may not otherwise be treatable but warning of a significant risk of serious complications.

Filed Under: News Well, Research & Development Tagged With: Clinical Trials, Covidien, ev3 Inc., Neurovascular repair

Layoffs: Covidien to shutter South Carolina plant, cutting 595 jobs

September 13, 2012 By MassDevice staff Leave a Comment

Covidien logo

Covidien (NYSE:COV) will close a manufacturing facility in Seneca, S.C., and move the operation to Costa Rica, resulting in nearly 600 layoffs.

The Seneca facility manufactures vascular products for the Mansfield, Mass.-based medical device company.

Filed Under: News Well, Vascular Tagged With: Boston Scientific, Covidien, ev3 Inc., Layoffs, stjudemedical

FDA warns on Covidien’s liquid embolic system following 9 patient deaths

July 10, 2012 By MassDevice staff Leave a Comment

Covidien logo

The FDA issued a safety alert after receiving reports of more than 100 adverse events, including 9 patient deaths, that may have been caused by Onyx brain blood vessel plugs made by Covidien (NYSE:COV) subsidiary ev3 Inc.

Filed Under: News Well Tagged With: Covidien, ev3 Inc., Neurovascular repair, Warning Letter

Covidien touts FDA clearance for “game-changing” Solitaire revascularization device

March 5, 2012 By MassDevice staff Leave a Comment

Soltaire FR device

Covidien plc (NYSE:COV) won FDA clearance for its Solitaire FR revascularization device for removing blood clots and restoring blood flow in the brains of patients suffering acute ischemic stroke.

The federal watchdog agency cleared the device, which physically removes blood clots from vessels, on the basis of data gathered during Covidien’s Swift study, the first of its kind to compare mechanical interventions for acute ischemic stroke, according to a press release.

Filed Under: News Well, Vascular Tagged With: Concentric Medical Inc., Covidien, ev3 Inc., Stryker

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS